25/06/2013
that Focal Adhesion Kinase (FAK) has a dose dependent effect in tumour growth and angiogenesis. This work emphasizes the importance of anti-angiogenic treatment in combating cancer and show that the effects of FAK inhibitors as anti-cancer agents are more complex than anticipated. The significance of this study is highlighted by the distribution of a press release from the NPG press office. It is has been also highlighted in Nature.com web page. For more information please contact